Hemodialysis market projected to reach US$ 26.59 billion by 2032

The global hemodialysis market is projected to experience significant growth, rising from an estimated US$ 15.44 billion in 2025 to approximately US$ 26.59 billion by 2032. This represents a compound annual growth rate (CAGR) of roughly 8.3% between 2026 and 2032.

Key drivers for this expansion include an increasing number of patients with end-stage renal disease, aging populations, and the rising prevalence of diabetes and hypertension. Market growth is further supported by improved access to treatment, expanded insurance coverage, and the development of dialysis centers.

The market is characterized by a concentrated competitive landscape. As of 2022, the top five companies—including Fresenius Medical Care, Nipro, B. Braun, and the former Baxter Kidney Care (which will operate independently as Vantive starting in 2025)—held a combined market share of approximately 65.03%.

In terms of product segments, dialyzers are expected to be the largest value segment, accounting for about 44.08% of the market in 2025. While dialysis centers and hospitals remain the primary locations for treatment, the home hemodialysis segment is anticipated to see a higher growth rate of approximately 11.11% between 2023 and 2029.